Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013–2017
暂无分享,去创建一个
V. Sintchenko | C. Tay | S. Octavia | R. Lan | N. Guiso | V. Timms | L. Luu | A. Keil | Zheng Xu | Michael Payne
[1] M. Tondella,et al. Complete Genome Sequences of Bordetella pertussis Isolates with Novel Pertactin-Deficient Deletions , 2017, Genome Announcements.
[2] Y. Arakawa,et al. Significant Decrease in Pertactin-Deficient Bordetella pertussis Isolates, Japan , 2017, Emerging infectious diseases.
[3] V. Sintchenko,et al. Characterisation of the Bordetella pertussis secretome under different media. , 2017, Journal of proteomics.
[4] Lori Rowe,et al. The History of Bordetella pertussis Genome Evolution Includes Structural Rearrangement , 2017, Journal of bacteriology.
[5] V. Sintchenko,et al. Genomic dissection of Australian Bordetella pertussis isolates from the 2008-2012 epidemic. , 2016, The Journal of infection.
[6] M. Quail,et al. Global Population Structure and Evolution of Bordetella pertussis and Their Relationship with Vaccination , 2014, mBio.
[7] V. Sintchenko,et al. Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia , 2014, Emerging infectious diseases.
[8] M. Tondella,et al. Prevalence and Molecular Characterization of Pertactin-Deficient Bordetella pertussis in the United States , 2013, Clinical and Vaccine Immunology.
[9] J. Miller,et al. Predicting the Functional Effect of Amino Acid Substitutions and Indels , 2012, PloS one.
[10] V. Sintchenko,et al. Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010. , 2012, The Journal of infectious diseases.
[11] Y. Arakawa,et al. Prevalence and Genetic Characterization of Pertactin-Deficient Bordetella pertussis in Japan , 2012, PloS one.
[12] R. George,et al. Genotypic Variation in the Bordetella pertussis Virulence Factors Pertactin and Pertussis Toxin in Historical and Recent Clinical Isolates in the United Kingdom , 2001, Infection and Immunity.
[13] R. Matthews,et al. Epitope mapping the Fim2 and Fim3 proteins of Bordetella pertussis with sera from patients infected with or vaccinated against whooping cough. , 1996, FEMS immunology and medical microbiology.
[14] V. Sintchenko,et al. Insight into evolution of Bordetella pertussis from comparative genomic analysis: evidence of vaccine-driven selection. , 2011, Molecular biology and evolution.